On March 5, 2025, The Hospital for Sick Children (SickKids) received a significant breakthrough in pediatric research with an $11.7 million award from Genome Canada. As part of the Canadian Precision Health Initiative, a total of $81 million in...
Latest Stories
After eight transformative years at the Ted Rogers Centre for Heart Research (TRCHR), Dr. Soror Sharifpoor is embarking on an exciting new chapter in her career. As the Director of Strategy & Translation at the Translational Biology and Engineering Program (TBEP)...
With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
NorthMiRs Inc., an innovative cardiovascular biotech start-up, has won $250,000 in funding from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 competition. Since its launch in 2018, the ECHO...
Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...
3D models of heart failure… stiffened hearts in diabetes…. saving infant lives
After a heart attack, this peptide protects the heart from further injury
Featured Event
ECHO PITCH 2024
Virtual Library
Visit our YouTube channel filled with world-class heart failure educational sessions on diverse topics
- This event has passed.
ECHO Webinar: Tamer Mohamed (Aspect Biosystems): Mar 30 (11 am – 12 pm)
March 30, 2021 @ 11:00 am - 12:00 pm EDT
Please join us for an ECHO webinar on Tuesday Mar 30, 2021 (11 am – 12 pm) featuring Tamer Mohamed (President & CEO, Aspect Biosystems). Tamer’s presentation entitled, “From Research to Commercialization: The Aspect Biosystems Journey to Bioprinted Therapeutics”, will feature an overview of Aspect Biosystems, its technologies and the story behind its success. Aspect Biosystems is a privately held biotechnology company combining the power of microfluidics and 3D bioprinting to fuel medical research and the development of bioprinted therapeutics.
Please register in advance for this meeting:
https://us02web.zoom.us/meeting/register/tZAtduCuqz0uHtw_gtLxT7Gd52EwEeHRSjXW
After registering, you will receive a confirmation email containing information about joining the webinar.